Video

Dr. Jamieson on Symptom Management in Myelofibrosis

Catriona Jamieson, MD, PhD, discusses symptom management in patients with myelofibrosis.

Catriona Jamieson, MD, PhD, the team leader for the Division of Hematology/Oncology at UC San Diego Health Moores Cancer Center, discusses symptom management in patients with myelofibrosis.

The best way to manage symptom burden for this patient population is to choose the appropriate treatment regimen, according to Jamieson. Previously, treatment options were limited for patients with myelofibrosis, and a larger focus was put on managing their quality of life vs their quantity of life, Jamieson says. However, these 2 factors are, in fact, intertwined, Jamieson notes. 

With the advent of better treatments that more effectively target the disease, both outcomes and symptoms have improved for patients, Jamieson explains. Currently, 2 FDA-approved agents are available for use in this population, but many promising agents are in the pipeline; these options will help to shift the focus in care from symptom management to disease modification for patients, Jamieson concludes.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity